OUTCOMES OF ENDOSCOPIC ENDONASAL TRANSSPHENOIDAL SURGERY FOR ACTH- SECRETING PITUITARY ADENOMAS AT VIET DUC HOSPITAL

Nguyễn Thành Nam1, Nguyễn Thanh Xuân2,
1 ietnam-Germany Friendship Hospital
2 Departement of Neurosurgery, Vietnam-Germany Friendship Hospital

Main Article Content

Abstract

Objective: To analyze results and complications of endoscopic transsphenoidal surgery in patients with ACTH- secreting pituitary adenomas. Methods: Retrospective and prospective study on 29 cases with ACTH- secreting pituitary adenomas (Cushing's disease) confirmed based on clinical features, laboratory findings, magnetic resonance imaging and treated by endoscopic transsphenoidal surgery at Viet Duc Hospital from October 2018 to September 2021. Results: The mean age was 42.7 years. There were 03 males (10%), and 26 females (90%), the ratio of female to male: 9/1. There were 6 cases of Microadenoma (20.7%), 23 cases of Macroadenoma (79.31%), the ratio of Microadenoma to Macroadenoma: 1/4. Surgical complications included transient diabetes insipidus (1 case), cerebrospinal fluid leak (1 case), symptomatic hyponatremia (5 cases) and all only needed medical treatment except 01 case of hydrocephalus treated by ventriculoperitoneal (VP) shunt. All Microadenoma cases were achieved gross total removal, twenty of 23 Macroadenoma cases were achieved subtotal removal. In total 9 cases admitted because of typical Cushing's syndrome, five of 6 cases of Microadenoma group and one of 3 cases of Macroadenoma group showed better changes in phenotype when re-examination after 3 months. Conclusion: endoscopic transsphenoidal pituitary surgery showed advantages such as safety and efficacy for ACTH- secreting pituitary adenomas treaaaatment.

Article Details

References

1. Buchfelder M, Nistor R, Fahlbusch R, Huk WJ. The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease. AJNR Am J Neuroradiol. 1993;14:1183–90.
2. Daniel M. PreveDello, M.D., NaDer Pouratian, M.D., Management of Cushing’s disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. Journal of Neurosurg 109:751–759, 2008.
3. Erickson D, Erickson B, Watson R, et al. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing’s syndrome. Clin Endocrinol (Oxf). 2010;72(6):793–9.
4. FitzPatrick M, Tartaglino LM, Hollander MD, Zimmerman RA, Flanders AE. Imaging of sellar and parasellar pathology. Radiol Clin North Am. 1999;37:101–21. x.
5. Samuel S. Shin, M.D., Ph.D., Paul A. Gardner, M.D.Endoscopic Endonasal Approach for ACTH- Secreting Pituitary Adenomas: Outcomes and Analysis of Remission Rates and Tumor Biochemical Activity with Respect to Tumor Invasiveness. World Neurosurgery. 2015. doi: 10.1016/j.wneu.2015.07.065.
6. Swearingen and B.M.K. Biller (eds.), Cushing’s Disease, Endocrine Updates, DOI 10.1007/978-1-4614-0011-0, © Springer Science+Business Media, LLC 2011.
7. Wolfsberger S, Ba-Ssalamah A, Pinker K, et al. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions. J Neurosurg. 2004;100: 278–86.